Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Colorectal Neoplasms 3Colonic Neoplasms 3Sarcopenia 2Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Stomach Neoplasms 1Seaweed Associated Changes in Healthy Subjects 1Rectal Neoplasms 1Proctitis 1Multiple Myeloma 1Mucositis 1Metabolic Syndrome 1Malnutrition 1Lymphoma 1Liver Failure 1Insulin Resistance 1Hyperandrogenism 1Head and Neck Neoplasms 1Glucose Intolerance 1Fibrosis 1Diarrhea 1Colonic Polyps 1Cholangiocarcinoma 1Chemotherapy-related Diarrhea 1Carcinoma, Hepatocellular 1Anovulation 1

Interventions

Cyclophosphamide 297Rituximab 272Etoposide 149Filgrastim 142fludarabine phosphate 120Cytarabine 109Vincristine 107Melphalan 102Radiotherapy 101Doxorubicin 97Peripheral Blood Stem Cell Transplantation 93Methotrexate 91fludarabine 86Prednisone 86Busulfan 86Tacrolimus 66Mycophenolic Acid 62Granulocyte Colony-Stimulating Factor 60Antilymphocyte Serum 58Dexamethasone 57Whole-Body Irradiation 55Carmustine 54Bortezomib 45Cyclosporine 44Lenalidomide 41Methylprednisolone 40sargramostim 39Bendamustine Hydrochloride 37ibritumomab tiuxetan 34Ifosfamide 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoma × maltodextrin × Clear all
NCT05135351 2026-04-20

Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy

University of Nebraska

Phase NA Recruiting
30 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡